Genomic surveillance of the evolving SARS-CoV-2 virus has been essential for managing the COVID-19 pandemic, helping researchers identify new variants, track their circulation, and create new vaccines that target the most common emerging variants. The same approach is applied when developing annual flu shots.
This article was originally published on MedicalXpress.com